Jared Gollob has been appointed chief medical officer of Cambridge, MA-based Kymera Therapeutics. Gollob most recently worked at Alynylam Pharmaceuticals (NASDAQ: ALNY) where he was vice president of clinical development and global vice president of medical affairs. Kymera is developing drugs based on protein degradation, the process cells use to rid themselves of harmful proteins.
UNDERWRITERS AND PARTNERS